EGFR and non-small cell lung carcinoma: As a possible resistance mechanism to EGFR mutant NSCLC, the upregulation of the EGFR signal pathway increased VEGF through hypoxia‐independent mechanisms; then the overexpression of VEGF family members plays a resistant role to EGFR‐TKIs.19